文献速递流行病学与生物统计真实世界研究与卫生经济

晚期慢性肾脏病透析启动时机对降低死亡和心血管事件的影响:全国队列研究

Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study.
PubMed 文献 · BMJ · 2021-11-29

该全国观察性队列研究纳入基线eGFR 10–20 mL/min/1.73 m2的晚期慢性肾脏病患者,采用克隆、删失和加权方法模拟临床试验,评估15种透析启动eGFR策略(4–19 mL/min/1.73 m2,步长1)对五年全因死亡和主要不良心血管事件的影响,以eGFR6–7为参照。结果显示死亡风险呈抛物线关系,eGFR15–16时风险最低,但需提前四年启动透析,作者认为对多数患者该获益可能不足以抵消更长的透析负担。

要点

  • 与eGFR6–7启动透析相比,eGFR15–16启动与五年绝对死亡风险降低5.1%(95%CI 2.5%–6.9%)相关。
  • eGFR15–16启动与主要不良心血管事件风险降低2.9%(95%CI 0.2%–5.5%)相关,HR为0.94(95%CI 0.91–0.98)。
  • 作者认为对多数患者,极早期启动透析的获益可能不足以抵消显著更长的透析时间负担。

核心结论

  • 极早期启动透析与死亡和心血管事件的适度降低相关,但对多数患者该降低可能不足以抵消显著更长的透析时间负担。

研究设计与样本

  • 全国观察性队列研究,使用瑞典国家肾脏登记处转诊至肾脏科的患者数据。
  • 纳入基线eGFR 10–20 mL/min/1.73 m2的患者,纳入时间为2007年1月1日至2016年12月31日,随访至2017年6月1日。
  • 采用克隆、删失和加权方法模拟临床试验的严格设计标准,以消除永生时间偏倚、领先时间偏倚和幸存者偏倚。
  • 使用动态边际结构模型估计15种透析启动策略(eGFR 4–19 mL/min/1.73 m2,步长1 mL/min/1.73 m2)的调整风险比和绝对风险,以eGFR6–7为参照。
  • 共纳入10 290例晚期慢性肾脏病患者,中位年龄73岁,女性3739例(36%),中位eGFR 16.8 mL/min/1.73 m2。

主要发现

  • 中位随访期间,3822例开始透析,4160例死亡,2446例发生主要不良心血管事件。
  • 死亡风险呈抛物线关系,eGFR15–16时风险最低。
  • 与eGFR6–7启动透析相比,eGFR15–16启动与五年绝对死亡风险降低5.1%(95%CI 2.5%–6.9%)相关,HR为0.89(95%CI 0.87–0.92)。
  • 与eGFR6–7启动透析相比,eGFR15–16启动与主要不良心血管事件风险降低2.9%(95%CI 0.2%–5.5%)相关,HR为0.94(95%CI 0.91–0.98)。
  • 5.1%的绝对风险差异对应于五年随访期间平均推迟死亡1.6个月,但透析需提前四年启动。

关键数值与推荐

  • 模拟IDEAL试验意图策略(eGFR10–14 vs eGFR5–7)时,全因死亡HR为0.96(95%CI 0.94–0.99)。
  • 模拟IDEAL试验实际达到的eGFR(eGFR7–10 vs eGFR5–7)时,全因死亡HR为0.97(95%CI 0.94–1.00)。

临床怎么用

  • 原文未据此给出推荐;作者结论指出极早期启动透析与死亡和心血管事件的适度降低相关,但对多数患者该降低可能不足以抵消显著更长的透析时间负担。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the optimal estimated glomerular filtration rate (eGFR) at which to initiate dialysis in people with advanced chronic kidney disease. DESIGN: Nationwide observational cohort study. SETTING: National Swedish Renal Registry of patients referred to nephrologists. PARTICIPANTS: Patients had a baseline eGFR between 10 and 20 mL/min/1.73 m2 and were included between 1 January 2007 and 31 December 2016, with follow-up until 1 June 2017. MAIN OUTCOME MEASURES: The strict design criteria of a clinical trial were mimicked by using the cloning, censoring, and weighting method to eliminate immortal time bias, lead time bias, and survivor bias. A dynamic marginal structural model was used to estimate adjusted hazard ratios and absolute risks for five year all cause mortality and major adverse cardiovascular events (composite of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) for 15 dialysis initiation strategies with eGFR values between 4 and 19 mL/min/1.73 m2 in increments of 1 mL/min/1.73 m2. An eGFR between 6 and 7 mL/min/1.73 m2 (eGFR6-7) was taken as the reference. RESULTS: Among 10 290 incident patients with advanced chronic kidney disease (median age 73 years; 3739 (36%) women; median eGFR 16.8 mL/min/1.73 m2), 3822 started dialysis, 4160 died, and 2446 had a major adverse cardiovascular event. A parabolic relation was observed for mortality, with the lowest risk for eGFR15-16. Compared with dialysis initiation at eGFR6-7, initiation at eGFR15-16 was associated with a 5.1% (95% confidence interval 2.5% to 6.9%) lower absolute five year mortality risk and 2.9% (0.2% to 5.5%) lower risk of a major adverse cardiovascular event, corresponding to hazard ratios of 0.89 (95% confidence interval 0.87 to 0.92) and 0.94 (0.91 to 0.98), respectively. This 5.1% absolute risk difference corresponded to a mean postponement of death of 1.6 months over five years of follow-up. However, dialysis would need to be started four years earlier. When emulating the intended strategies of the Initiating Dialysis Early and Late (IDEAL) trial (eGFR10-14 v eGFR5-7) and the achieved eGFRs in IDEAL (eGFR7-10 v eGFR5-7), hazard ratios for all cause mortality were 0.96 (0.94 to 0.99) and 0.97 (0.94 to 1.00), respectively, which are congruent with the findings of the randomised IDEAL trial. CONCLUSIONS: Very early initiation of dialysis was associated with a modest reduction in mortality and cardiovascular events. For most patients, such a reduction may not outweigh the burden of a substantially longer period spent on dialysis.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Fu EL, Evans M, Carrero JJ, et al. Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study. BMJ. 2021. PMID: 34844936. doi:10.1136/bmj-2021-066306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。